Usefulness of assessment of circulating tumor DNA(ctDNA) of cerebrospinal fluid(CSF) samples for early detection of brain metastasis (BrM) in patients with triple-negative breast cancer (TNBC).

被引：0
|
作者：
Raimondi, Lucrezia
Naso, Giuseppe
Lazzeroni, Rachele
Di Benedetto, Laura
Raimondi, Filippo Maria
Di Rocco, Arianna
Giaconi, Laura
Rossi, Luigi
Spinelli, Gian Paolo
机构：
[1] Sapienza Univ Rome, UOC Terr Oncol Aprilia, Aprilia, Italy
[2] Policlin Umberto 1, Div Med Oncol, Rome, Italy
[3] Sapienza Univ Rome, Dept Med & Surg Sci & Translat Med, St Andrea Univ Hosp, Rome, Italy
[4] BIOS SpA, Rome, Italy
[5] E Campus Univ, Rome, Italy
[6] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[7] Sapienza Univ Rome, Clin & Mol Med Dept, Rome, Italy
[8] Sapienza Univ Rome, OC Terr Oncol Aprilia, AUSL Latina, Aprilia, Italy
[9] Sapienza Univ Rome, AUSL Latina, UOC Terr Oncol Aprilia, Aprilia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
507
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma.
    Holle, Bridget M.
    Nandakumar, Subhiksha
    Kreitzer, Christoph
    Song, Timothy
    Tartaro, Marlene
    Hertz, Charli Ann
    Rafailov, Johnathan
    Campos, Carl
    Reiner, Anne S.
    Young, Robert J.
    Meng, Alicia
    Pasquini, Luca
    Brannon, Angela Rose
    Socci, Nicholas D.
    Arcila, Maria E.
    Solit, David B.
    Berger, Michael F.
    Schultz, Nikolaus
    Mellinghoff, Ingo K.
    Miller, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] UTILITY OF CIRCULATING TUMOR DNA (CTDNA) FROM CEREBROSPINAL FLUID (CSF) FOR PROGNOSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
    Holle, B. M.
    Nandakumar, S.
    Kreitzer, C.
    Song, T.
    Tartaro, M.
    Hertz, C. A. J.
    Rafailov, J.
    Campos, C.
    Reiner, A. S.
    Young, R.
    Meng, A.
    Pasquini, L.
    Brannon, A.
    Socci, N. D.
    Arcila, M. E.
    Solit, D. B.
    Berger, M. F.
    Schultz, N.
    Mellinghoff, I. K.
    Miller, A. M.
    NEURO-ONCOLOGY, 2024, 26 : V19 - V20
  • [33] UTILITY OF CIRCULATING TUMOR DNA (CTDNA) FROM CEREBROSPINAL FLUID (CSF) FOR PROGNOSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
    Miller, Alexandra M.
    Nandakumar, Subhiksha
    Holle, Bridget M.
    Kreitzer, Christoph
    Song, Timothy
    Tartaro, Marlene
    Hertz, Charli Ann J.
    Rafailov, Johnathan
    Campos, Carl
    Brannon, A. Rose
    Solit, David B.
    Pasquini, Luca
    Meng, Alicia
    Reiner, Anne
    Young, Robert
    Socci, Nicholas D.
    Arcila, Maria E.
    Berger, Michael F.
    Schultz, Nikolaus
    Mellinghoff, Ingo K.
    NEURO-ONCOLOGY, 2024, 26
  • [34] Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
    Zaikova, Elena
    Cheng, Brian Y. C.
    Cerda, Viviana
    Kong, Esther
    Lai, Daniel
    Lum, Amy
    Bates, Cherie
    den Brok, Wendie
    Kono, Takako
    Bourque, Sylvie
    Chan, Angela
    Feng, Xioalan
    Fenton, David
    Gurjal, Anagha
    Levasseur, Nathalie
    Lohrisch, Caroline
    Roberts, Sarah
    Shenkier, Tamara
    Simmons, Christine
    Taylor, Sara
    Villa, Diego
    Miller, Ruth
    Aguirre-Hernandez, Rosalia
    Aparicio, Samuel
    Gelmon, Karen
    NPJ BREAST CANCER, 2024, 10 (01)
  • [35] Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
    Elena Zaikova
    Brian Y. C. Cheng
    Viviana Cerda
    Esther Kong
    Daniel Lai
    Amy Lum
    Cherie Bates
    Wendie den Brok
    Takako Kono
    Sylvie Bourque
    Angela Chan
    Xioalan Feng
    David Fenton
    Anagha Gurjal
    Nathalie Levasseur
    Caroline Lohrisch
    Sarah Roberts
    Tamara Shenkier
    Christine Simmons
    Sara Taylor
    Diego Villa
    Ruth Miller
    Rosalia Aguirre-Hernandez
    Samuel Aparicio
    Karen Gelmon
    npj Breast Cancer, 10
  • [36] Detection of circulating tumor DNA (ctDNA) in untreated patients (pts) with cancer: Implications for early cancer detection (ECD)
    Nakamura, Y.
    Tin, T.
    Krinshpun, S.
    Mitchell, B.
    Bristow, S. L.
    Aleshin, A.
    Magbanua, M. J. M.
    Van't Veer, L. J.
    Chapman, J.
    Andersen, C. Lindbjerg
    Tan, D. S. W.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S717 - S717
  • [37] Impact of post-treatment ctDNA and residual cancer burden (RCB) on outcomes in patients with triple-negative breast cancer (TNBC) and residual disease
    Sharma, Priyanka
    Stecklein, Shane R.
    Kimler, Bruce F.
    Yoder, Rachel
    Schwensen, Kelsey
    Staley, Joshua M.
    Khan, Qamar J.
    O'Dea, Anne P.
    Nye, Lauren E.
    Elia, Manana
    Heldstab, Jaimie
    Home, Trisha
    Hyter, Stephen
    Isakova, Kamilla
    Pathak, Harsh B.
    Godwin, Andrew K.
    CANCER RESEARCH, 2022, 82 (04)
  • [38] Circulating tumor DNA (ctDNA) during and after neoadjuvant chemotherapy and prior to surgery is a powerful prognostic factor in triple-negative breast cancer (TN BC).
    Cavallone, Luca
    Aguilar, Adriana
    Aldamry, Mohammed
    Lafleur, Josiane
    Brousse, Susie
    Lan, Cathy
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Pelmus, Manuela
    Ferrario, Cristiano
    Marcus, Elizabeth A.
    Robidoux, Andre
    Discepola, Federico
    Basik, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Characterization of disseminated Tumor Cells (DTCs) in the Bone Marrow of Female Patients with Triple-negative Breast Cancer (TNBC)
    Eckardt, A.
    Weydandt, L.
    Hoehn, A. -K.
    Aktas, B.
    Nel, I.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (06) : E23 - E23
  • [40] Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Zhang, Diana
    Jahanfar, Shayesteh
    Rabinowitz, Judy B.
    Dower, Joshua
    Song, Fei
    Wu, Cherng-Horng
    Hu, Xiao
    Tracy, Phillip
    Basik, Mark
    Medford, Arielle
    Lin, Po-Han
    Huang, Chiun-Sheng
    Bidard, Francois-Clement
    Renault, Shufang
    Pai, Lori
    Buss, Mary
    Parsons, Heather A.
    Schlam, Ilana
    BREAST CANCER RESEARCH, 2025, 27 (01)
12345